B. Hurley

发表

The Growing Regulation of Conversion Therapy.

M. Barber, A. Schwartz, D. Tompkins, 2016, Journal of medical regulation.

Expanding access to medications for opioid use disorder in primary care clinics: an evaluation of common implementation strategies and outcomes

D. Almirall, M. McGovern, B. Hurley, 2022, Implementation Science Communications.

COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics

M. McGovern, B. Hurley, H. C. Garneau, 2021, Journal of General Internal Medicine.

The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral healthcare utilization and spending among enrollees with substance use disorders.

S. Ettner, F. Azocar, J. Harwood, 2017, Journal of substance abuse treatment.

Prognostic outcomes after the initiation of an electronic telemedicine intensive care unit (eICU) in a rural health system.

E. Zawada, B. Hurley, Kelly A. Burdge, 2006, South Dakota medicine : the journal of the South Dakota State Medical Association.

The Integrating Medications for Addiction Treatment (IMAT) Index: A measure of capability at the organizational level.

M. McGovern, Hélène Chokron Garneau, B. Hurley, 2021, Journal of substance abuse treatment.

Organizational Capacity and Readiness to Provide Medication for Individuals with Co-Occurring Alcohol Use Disorders in Public Mental Health Settings

Allison J. Ober, K. Watkins, S. Hunter, 2021, Administration and Policy in Mental Health and Mental Health Services Research.

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

L. Ray, K. Miotto, E. Grodin, 2022, Drugs.

Organizing Publicly Funded Substance Use Disorder Treatment in the United States: Moving Toward a Service System Approach.

D. Urada, R. Rawson, Traci R. Rieckmann, 2016, Journal of substance abuse treatment.

Using massive health insurance claims data to predict very high-cost claimants: a machine learning approach pdf

Alexander Gutfraind, Yanchun Xu, Brian Hurley, 2019, ArXiv.

Embedding comprehensive smoking cessation programs into community clinics: study protocol for a cluster-randomized controlled trial

L. Ray, T. Friedman, Martin L. Lee, 2022, Trials.

Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone

Allison J. Ober, K. Watkins, L. Ecola, 2020, Addiction Science & Clinical Practice.

Safety Net Provider Attitudes Toward Smoking Cessation Treatment

L. Ray, T. Friedman, Susan Hsieh, 2021, Frontiers in Psychiatry.

Outcomes of two quality improvement implementation interventions for depression services in adults with substance use problems

K. Wells, K. Watkins, Lingqi Tang, 2020, The American journal of drug and alcohol abuse.

Opioid Use Disorder Among Clients of Community Mental Health Clinics: Prevalence, Characteristics, and Treatment Willingness.

K. Watkins, S. Hunter, E. Bromley, 2021, Psychiatric Services.

Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): process of adapting collaborative care for co-occurring opioid use and mental disorders

Alex R. Dopp, K. Watkins, L. Meredith, 2022, Addiction Science & Clinical Practice.

Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities.

Alex R. Dopp, K. Osilla, C. Kase, 2021, Journal of substance abuse treatment.

An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for fibromyalgia

N. Bellamy, J. Campbell, N. Dudek, 2008, InflammoPharmacology.

Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.

Allison J. Ober, K. Watkins, E. Bromley, 2020, Journal of substance abuse treatment.